Hune encourages license revocation in fungal meningitis outbreak

LANSING — Following the Centers for Disease Control and Prevention’s (CDC) identification of 41 fungal meningitis cases in Michigan, Sen. Joe Hune encourages the suspension of New England Compounding Center’s (NECC) pharmacy license.

“Three of the 41 cases in Michigan have resulted in death. There is absolutely no doubt that NECC’s pharmacy license should be suspended,” said Hune, R-Hamburg Township. “The safety of families across the 22nd Senate District and entire state of Michigan is a top priority. I strongly encourage NECC’s license be suspended immediately.”

Gov. Rick Snyder and Michigan Attorney General Bill Schuette filed an administrative complaint and order of summary suspension against NECC, the company at the center of the fungal meningitis outbreak, on Oct. 12.

According to a statement released by Schuette, once the order of summary suspension has been signed by the Bureau of Health Professions director, NECC’s license will be immediately suspended and the company will be forced to cease operations in Michigan.

A multistate investigation of meningitis among patients who received steroid injections is being conducted by the CDC and the U.S. Food and Drug Administration. The cause of the outbreak may be a potentially contaminated product manufactured at NECC.

The four facilities in Michigan that received a contaminated lot of preservative-free methylprednisolone acetate prepared by NECC are:

  • Michigan Neurosurgical Institutes in Grand Blanc;
  • Michigan Pain Specialists in Brighton;
  • Neuromuscular and Rehabilitation in Traverse City; and
  • Southeast Michigan Surgical Hospital in Warren.

All four facilities are working with the Michigan Department of Community Health to ensure that patients who may have received the contaminated product are notified.

Earlier this month, NECC issued a voluntary recall of all its products in circulation that were produced and distributed from its Framingham, Massachusetts facility.

For more information on the recall, including a list of affected medications, visit: